SEC Filing Summary: Form 13F Information Table
Business Context and Reporting Period
Company: CINCINNATI FINANCIAL CORP
Filing Type: Form 13F Information Table
Reporting Period: The filing text does not explicitly state the quarter end date in the narrative, though the metadata indicates a date of 2026 Jun 30. The table lists holdings as of the reporting period.
This filing discloses the equity securities held by the investment manager. It does not contain financial performance data (revenue, profit, cash flow) for Cincinnati Financial Corp itself, but rather details its investment portfolio.
Key Financial Metrics and Portfolio Composition
The filing provides a list of equity holdings with the following metrics for each position:
- Value: Total market value of the holding (in dollars).
- Shares: Number of shares or principal amount.
- Voting Authority: All listed positions are held with "Sole" voting authority.
- Derivatives: No Put or Call options are reported in this table.
Top Holdings by Value (Selected):
| Issuer | Value (USD) | Shares |
|---|---|---|
| Apple Inc. | $809,344,550 | 2,797,016 |
| Broadcom Inc. | $397,037,915 | 1,051,060 |
| UnitedHealth Group | $194,856,488 | 468,822 |
| Philip Morris International | $199,308,547 | 1,101,700 |
| Norfolk Southern | $180,664,947 | 574,287 |
| Microsoft Corp. | $183,208,773 | 491,150 |
Material Changes and Comparisons
The filing text does not provide data for the prior comparable period. Therefore, material changes in holdings, percentage shifts, or net purchases/sales cannot be calculated from this document alone.
Guidance, Outlook, and Risks
Management Commentary: None provided. Form 13F is a regulatory disclosure of holdings and does not include management discussion, guidance, or outlook.
Risks and Contingencies: The filing includes a standard disclaimer that the SEC has not reviewed the information for accuracy or completeness. No specific risk factors or contingencies regarding the portfolio are detailed in this table.
Key Facts for Investor Verification
- Portfolio Concentration: Verify the total portfolio value by summing the "Value" column to assess concentration risk relative to the company's total assets.
- Top 10 Holdings: Confirm the weight of the largest positions (e.g., Apple, Broadcom, UnitedHealth) to understand sector exposure.
- Voting Control: Note that the manager exercises "Sole" voting authority on all listed positions, indicating full control over corporate actions for these shares.
- Absence of Derivatives: Verify that no Put or Call options are held, as the "Put/Call" column is empty for all entries.
- Reporting Date Discrepancy: Cross-reference the metadata date (2026 Jun 30) with the actual filing date to ensure the data reflects the intended reporting period.